| GWAS |
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885
)
- Body mass index ( 22446040
)
- Breast cancer ( 17903305
)
- Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes ( 29221444
)
- Forehead morphology ( 29921221
)
- Generalized epilepsy ( 30531953
)
- Glucocorticoid-induced osteonecrosis ( 26265699
)
- HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction ( 31806883
)
- Hepatocellular carcinoma ( 22807686
)
- Hyperactive-impulsive symptoms ( 18821565
)
- Lung cancer ( 34062886
)
- Periodontitis (DPAL) ( 24024966
)
- Plasma parathyroid hormone levels ( 30134803
)
- Refractive error ( 32231278
)
- Response to statin therapy ( 20339536
)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027
)
|
- Alanine aminotransferase levels in non-alcoholic fatty liver disease ( 31311600
)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028
)
- Forced expiratory volume in 1 second (environmental tobacco smoke interaction) ( 28738859
)
- Iron status biomarkers (total iron binding capacity) ( 28334935
)
- Iron status biomarkers (transferrin saturation) ( 28334935
)
- Metabolite levels ( 23823483
)
- Neuroticism ( 27067015
)
- Post bronchodilator FEV1/FVC ratio ( 26634245
)
- Schizophrenia ( 23894747
)
|
